1 | industry | 2,127 |
2 | stones | 2,073 |
3 | companies | 1,322 |
4 | company | 715 |
5 | calculi | 678 |
6 | industries | 347 |
7 | diverticulum | 147 |
8 | factory | 136 |
9 | mill | 121 |
10 | lithiasis | 116 |
11 | diverticula | 100 |
12 | outlets | 94 |
13 | factories | 72 |
14 | enterprises | 71 |
15 | dyssynergia | 64 |
16 | firms | 60 |
17 | processors | 44 |
18 | mills | 41 |
19 | uroliths | 32 |
20 | dyeing | 30 |
21 | handlers | 24 |
22 | sterilizations | 20 |
23 | calculosis | 19 |
24 | dealers | 18 |
25 | pharmaceutics | 16 |
26 | bowls | 12 |
27 | concrements | 12 |
28 | hydrazines | 9 |
29 | refineries | 8 |
30 | diverticulae | 7 |
31 | microabscesses | 7 |
32 | qinjiao | 7 |
33 | dyscoordination | 5 |
34 | sisterlove | 5 |
35 | preparer | 4 |
36 | siding | 4 |
37 | knowledgebase | 3 |
38 | mono-interventions | 3 |
39 | companies/manufacturers | 2 |
40 | kaopectate | 2 |
41 | rawal | 2 |
42 | swatches | 2 |
43 | urocystoliths | 2 |
44 | 'buoy | 1 |
45 | 'cohen | 1 |
46 | administration-indicated | 1 |
47 | cd26/dpp-iv | 1 |
48 | companies.our | 1 |
49 | company-funded | 1 |
50 | contamination.in | 1 |
51 | dm/cow/day | 1 |
52 | domotics | 1 |
53 | dyssinergia | 1 |
54 | hf-therapy | 1 |
55 | hypertony | 1 |
56 | interventions/modifications | 1 |
57 | intrasinusal | 1 |
58 | journals/chinese | 1 |
59 | kidney-21 | 1 |
60 | manufacturer-supported | 1 |
61 | ovary-human | 1 |
62 | ovary-k | 1 |
63 | overactivity/oab | 1 |
64 | prooxidatively | 1 |
65 | rary | 1 |
66 | roll-call | 1 |
67 | stent-ing | 1 |
68 | stone-1 | 1 |
69 | stones-2 | 1 |
70 | tô | 1 |
71 | valcophen | 1 |
1 | 'buoy | 1 |
2 | 'cohen | 1 |
3 | administration-indicated | 1 |
4 | bowls | 12 |
5 | calculi | 678 |
6 | calculosis | 19 |
7 | cd26/dpp-iv | 1 |
8 | companies | 1,322 |
9 | companies.our | 1 |
10 | companies/manufacturers | 2 |
11 | company | 715 |
12 | company-funded | 1 |
13 | concrements | 12 |
14 | contamination.in | 1 |
15 | dealers | 18 |
16 | diverticula | 100 |
17 | diverticulae | 7 |
18 | diverticulum | 147 |
19 | dm/cow/day | 1 |
20 | domotics | 1 |
21 | dyeing | 30 |
22 | dyscoordination | 5 |
23 | dyssinergia | 1 |
24 | dyssynergia | 64 |
25 | enterprises | 71 |
26 | factories | 72 |
27 | factory | 136 |
28 | firms | 60 |
29 | handlers | 24 |
30 | hf-therapy | 1 |
31 | hydrazines | 9 |
32 | hypertony | 1 |
33 | industries | 347 |
34 | industry | 2,127 |
35 | interventions/modifications | 1 |
36 | intrasinusal | 1 |
37 | journals/chinese | 1 |
38 | kaopectate | 2 |
39 | kidney-21 | 1 |
40 | knowledgebase | 3 |
41 | lithiasis | 116 |
42 | manufacturer-supported | 1 |
43 | microabscesses | 7 |
44 | mill | 121 |
45 | mills | 41 |
46 | mono-interventions | 3 |
47 | outlets | 94 |
48 | ovary-human | 1 |
49 | ovary-k | 1 |
50 | overactivity/oab | 1 |
51 | pharmaceutics | 16 |
52 | preparer | 4 |
53 | processors | 44 |
54 | prooxidatively | 1 |
55 | qinjiao | 7 |
56 | rary | 1 |
57 | rawal | 2 |
58 | refineries | 8 |
59 | roll-call | 1 |
60 | siding | 4 |
61 | sisterlove | 5 |
62 | stent-ing | 1 |
63 | sterilizations | 20 |
64 | stone-1 | 1 |
65 | stones | 2,073 |
66 | stones-2 | 1 |
67 | swatches | 2 |
68 | tô | 1 |
69 | urocystoliths | 2 |
70 | uroliths | 32 |
71 | valcophen | 1 |
1 | stone-1 | 1 |
2 | kidney-21 | 1 |
3 | stones-2 | 1 |
4 | dyssinergia | 1 |
5 | dyssynergia | 64 |
6 | diverticula | 100 |
7 | overactivity/oab | 1 |
8 | company-funded | 1 |
9 | administration-indicated | 1 |
10 | manufacturer-supported | 1 |
11 | diverticulae | 7 |
12 | knowledgebase | 3 |
13 | journals/chinese | 1 |
14 | kaopectate | 2 |
15 | sisterlove | 5 |
16 | stent-ing | 1 |
17 | siding | 4 |
18 | dyeing | 30 |
19 | calculi | 678 |
20 | ovary-k | 1 |
21 | intrasinusal | 1 |
22 | rawal | 2 |
23 | roll-call | 1 |
24 | mill | 121 |
25 | diverticulum | 147 |
26 | ovary-human | 1 |
27 | 'cohen | 1 |
28 | valcophen | 1 |
29 | contamination.in | 1 |
30 | dyscoordination | 5 |
31 | qinjiao | 7 |
32 | preparer | 4 |
33 | companies.our | 1 |
34 | domotics | 1 |
35 | pharmaceutics | 16 |
36 | swatches | 2 |
37 | companies | 1,322 |
38 | refineries | 8 |
39 | factories | 72 |
40 | industries | 347 |
41 | hydrazines | 9 |
42 | stones | 2,073 |
43 | enterprises | 71 |
44 | microabscesses | 7 |
45 | uroliths | 32 |
46 | urocystoliths | 2 |
47 | lithiasis | 116 |
48 | calculosis | 19 |
49 | mills | 41 |
50 | bowls | 12 |
51 | firms | 60 |
52 | interventions/modifications | 1 |
53 | sterilizations | 20 |
54 | mono-interventions | 3 |
55 | dealers | 18 |
56 | handlers | 24 |
57 | companies/manufacturers | 2 |
58 | processors | 44 |
59 | outlets | 94 |
60 | concrements | 12 |
61 | cd26/dpp-iv | 1 |
62 | dm/cow/day | 1 |
63 | prooxidatively | 1 |
64 | company | 715 |
65 | hypertony | 1 |
66 | 'buoy | 1 |
67 | hf-therapy | 1 |
68 | rary | 1 |
69 | factory | 136 |
70 | industry | 2,127 |
71 | tô | 1 |